[Inoa Latina] Brassica oleracea L.var.italica L.

[Plant Source] mai Kina

10:1

[Hōʻike] ʻōmaʻomaʻo māmā i ka pauka ʻōmaʻomaʻo

Māhele Mea kanu i hoʻohana ʻia: mea kanu holoʻokoʻa

[Particle nui] 60 Mesh

[Nalo ma ka maloʻo] ≤8.0%

[Mea Kaumaha] ≤10PPM

[Storage] E kūʻai ma kahi maloʻo a maloʻo, e mālama i ka mālamalama pololei a me ka wela.

24 Mahina

[Package] Hoʻopili ʻia i loko o nā pahu pahu pepa a me ʻelua ʻeke plastik i loko.

[Kapaona paona] 25kgs/pahu

He lālā ʻo Broccoli no ka ʻohana kāpeti, a pili pili i ka pua pua. No Italia kona mahi ana. ʻO Broccolo, kona inoa ʻItalia, ʻo ia hoʻi, "ʻopuu kāpeti." Ma muli o kāna mau ʻāpana like ʻole, hāʻawi ka broccoli i nā ʻano ʻono a me nā ʻano like ʻole, mai ka palupalu a me ka pua (ka pua) a hiki i ka fibrous a crunchy (ke kumu a me ke kumu). Loaʻa i ka Broccoli nā glucosinolates, nā phytochemical e wāwahi i nā pūhui i kapa ʻia ʻo indoles a me isothiocyanates (e like me ka sulphoraphane). Loaʻa i ka Broccoli ka carotenoid, lutein. ʻO Broccoli kahi kumu maikaʻi loa o nā huaora K, C, a me A, a me ka folate a me ka fiber. ʻO Broccoli kahi kumu maikaʻi loa o ka phosphorus, potassium, magnesium a me nā huaora B6 a me E.

Hana Nui

(1) Me ka hana o ka anti-cancer, a me ka hoʻomaikaʻi maikaʻi ʻana i ka hiki o ke koko scavenging;

(2) Loaʻa ka hopena nui e pale a hoʻoponopono i ka hypertension;

(3) Me ka hana o ka hoʻonuiʻana i ke akepaʻa detoxification, hoʻomaikaʻi i ka palekana;

(4) .Me ka hana o ka hoemi koko koko a me ka cholesterol.

4. Noi

(1) E like me nā lāʻau lapaʻau maka o ka anti-cancer, ua hoʻohana nui ʻia i ka lāʻau lapaʻau;

(2) Hoʻohana ʻia ma ke kahua huahana olakino, hiki ke hoʻohana ʻia e like me ka mea maka i ka meaʻai olakino, ʻo ke kumu e hoʻonui ai i ka palekana.

(3) Hoʻohana ʻia i nā māla meaʻai, hoʻohana nui ʻia e like me ka meaʻai meaʻai hana.

koho maoli stevia

Kūkākūkā ka pelekikena mua o ACP, ʻo Kauka Sandra Fryhofer, he lālā o ke Kōmike Hoʻomaʻamaʻa ACP, i nā hoʻololi koʻikoʻi i ka papa hana hoʻomaʻamaʻa kanaka makua ACIP 2013 i paʻi ʻia ma Annals of Internal Medicine https://annals.org/article.aspx?articleid=1567229.

Philadelphia, Ianuali 29, 2012 — Ua hoʻolaha ke Kōmike Aʻoaʻo o ka Center for Disease Control and Prevention on Immunization Practices (ACIP) i kāna papa hana lāʻau lapaʻau makua i manaʻo ʻia no ka makahiki 2013 e loaʻa ana nā mea hou i ka pneumococcal, Tdap (tetanus, diphtheria, a me acellular pertussis), a me ka maʻi maʻi. nā lāʻau lapaʻau. Ma muli o ka haʻahaʻa o ka loaʻa ʻana o ka lāʻau lapaʻau i kēia manawa, koi pū ʻo ACIP i nā mea mālama ola kino e loiloi mau i nā moʻolelo o ka lāʻau lapaʻau maʻi a hoʻokō i nā hoʻolālā hana e hoʻonui ai i ka pili. E paʻi ʻia kēia ʻōlelo aʻoaʻo ma Annals of Internal Medicine, ka puke pai nui o ka American College of Physicians (ACP).

No ka manawa mua, ua hoʻohui ʻia ka ʻike e pili ana i ka hoʻohana ʻana i ka 13-valent pneumococcal conjugate vaccine (PCV13) i ka papa kuhikuhi. Pono e hoʻohana ʻia ka PCV13 me ka 23-valent pneumococcal polysaccharide vaccine (PPSV23) no ka poʻe makua i hoʻopaʻa ʻia i ka immunocompromised, a i ʻole ka poʻe i loaʻa i nā maʻi e like me ka maʻi HIV, ka maʻi maʻi, a i ʻole ka maʻi maʻi kiʻekiʻe. Aia i loko o ka papahana ka ʻike e pili ana i ka manawa o ka lawelawe ʻana i nā lāʻau lapaʻau a wehewehe pū nō hoʻi i ka poʻe mākua e pono ai i hoʻokahi a ʻelua paha kaila o PPSV23 ma mua o ka makahiki 65.

Ua hoʻonui ʻia nā ʻōlelo manaʻo no ka lāʻau lapaʻau Tdap e hoʻokomo i ka hoʻomaʻamaʻa maʻamau o nā pākeke he 65 a ʻoi aku paha a no nā wahine hāpai e loaʻa i ka maʻi Tdap me kēlā me kēia hāpai ʻana. ʻO ka manawa kūpono o ka lāʻau lapaʻau ʻo Tdap i ka wā hāpai ʻana, aia ma ke kolu o ka trimester, ma waena o 27 a me 36 wiki o ka hāpai ʻana. Ua hana ʻia kēia ʻōlelo aʻoaʻo no ka mālama ʻana i ka wahine hāpai a me kāna pēpē, ʻoiai e hele ana nā antibodies pale i ka ʻōpū. He ʻōpiopio loa nā kamaliʻi no ka lāʻau lapaʻau akā ʻoi aku ka nui o ka pilikia no ka maʻi koʻikoʻi a i ʻole ka make mai ka pertussis.

Pono nā poʻe maʻi a pau i piha i ka 6 mahina a ʻoi aʻe e hoʻomau i ke kaʻi ʻana i ka maʻi influenza. ʻAʻole he contraindication hou ka maʻi maʻi hua moa, akā ʻo ka poʻe maʻi me ka maʻi maʻi hua e pono ke kiʻi i ka pana maʻi i hoʻohana ʻole ʻia no ka mea ʻo ia ka mea i aʻo ʻia. Ua ʻae ka US Food and Drug Administration i ka lāʻau lapaʻau quadrivalent influenza i loaʻa i ʻelua mau maʻi maʻi maʻi influenza B e hoʻonui i ka hiki ke hāʻawi ka lāʻau lapaʻau i ka antibody cross-reactive e kūʻē i kahi kiʻekiʻe o nā maʻi maʻi maʻi influenza B.

Aia ka ACIP me ACP a me 16 mau hui lapaʻau ʻē aʻe e hōʻike ana i nā wahi hana lapaʻau like ʻole. I kēlā me kēia makahiki, nānā ka ACIP i ka Papa Hoʻopaʻa Kano Kano i Manaʻo ʻia e ka CDC e hōʻoia i ka hōʻike ʻana o ka papa kuhikuhi i nā manaʻo lapaʻau o kēia manawa no nā lāʻau lapaʻau laikini. Manaʻo ʻia nā ʻōlelo paipai e alakaʻi i nā kauka a me nā kauka ʻē aʻe e pili ana i nā lāʻau lapaʻau kūpono no kā lākou poʻe maʻi makua. Ma ʻOkakopa 2010, ua ʻae ka ACIP i kahi kaʻina hana e pili ana i nā hōʻike e noʻonoʻo ana i ka maikaʻi o nā hōʻike, nā pōmaikaʻi a me nā pōʻino, nā waiwai a me nā makemake o nā heluna kanaka i hoʻopilikia ʻia, a me ka hopena waiwai.

Hiki ke 'ike 'ia ka Papa Ho'ola La'i Ka'i 'Ai 'Ai 'Ai 'Ai 'O ka makahiki 2013, me ka 'ike e pili ana i nā kano kano 'ē a'e a me nā ho'ololi 'ana i nā footnote, ma www.annals.org.